
|Articles|August 1, 2019
China Invests in Gene Therapy Research
Researchers in China are playing a role in advancing gene therapy development.
Advertisement
With a growing need for therapies to treat diseases in its growing population, researchers in China are playing a role in advancing gene therapy development. Eric Langer, managing partner, BioPlan Associates, highlights trends in this market in an interview with BioPharm International.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
A-TEEM: A Novel, Powerful Tool for Evaluating and Monitoring Cell Culture Media
2
Challenges, Innovations, and Future Outlook of Biologics Formulations
3
Behind the Headlines Episode 27: Unpacking Mega Deals and R&D Directions
4
Global Study Confirms Survival Advantage of Mogamulizumab in Advanced Mycosis Fungoides and Sézary Syndrome
5